Search

Integration of CO2 capture capability from simulated flue gas and electrochemical CO2 reduction reaction (eCO2RR) active sites into a catalyst is a promising cost‐effective strategy for carbon neutrality, but is of great difficulty. Herein, combining the mixed gas breakthrough experiments and eCO2RR tests, we showed that an Ag12 cluster‐based metal–organic framework (1‐NH2, aka Ag12bpy‐NH2), simultaneously possessing CO2 capture sites as "CO2 relays" and eCO2RR active sites, can not only utilize its micropores to efficiently capture CO2 from simulated flue gas (CO2 : N2=15 : 85, at 298 K), but also catalyze eCO2RR of the adsorbed CO2 into CO with an ultra‐high CO2 conversion of 60 %. More importantly, its eCO2RR performance (a Faradaic efficiency (CO) of 96 % with a commercial current density of 120 mA cm−2 at a very low cell voltage of −2.3 V for 300 hours and the full‐cell energy conversion efficiency of 56 %) under simulated flue gas atmosphere is close to that under 100 % CO2 atmosphere, and higher than those of all reported catalysts at higher potentials under 100 % CO2 atmosphere. This work bridges the gap between CO2 enrichment/capture and eCO2RR. [ABSTRACT FROM AUTHOR]

Electroreduction of CO2 to CO is a promising approach for the cycling use of CO2, while it still suffers from impractical current density and durability. Here we report a single‐atom nanozyme (Ni−N5−C) that achieves industrial‐scale performance for CO2‐to‐CO conversion with a Faradaic efficiency (FE) exceeded 97 % over −0.8–−2.4 V vs. RHE. The current density at −2.4 V vs. RHE reached a maximum of 1.23 A cm−2 (turnover frequency of 69.7 s−1) with an FE of 99.6 %. No obvious degradation was observed over 100 hours of continuous operation. Compared with the planar Ni−N4 site, the square‐pyramidal Ni−N5 site has an increase and a decrease in the dz2 ${{{\rm d}}_{{z}^{2}}}$ and dxz/yz orbital energy levels, respectively, as revealed by density functional theory calculations. Thus, the Ni−N5 catalytic site is more superior to activate CO2 molecule and reduce the energy barriers as well as promote the CO desorption, thus boosting the kinetic activation process and catalytic activity. [ABSTRACT FROM AUTHOR]

CRISPR/Cas is a revolutionary gene editing technology with wide-ranging utility. The safe, non-viral delivery of CRISPR/Cas components would greatly improve future therapeutic utility. We report the synthesis and development of zwitterionic amino lipids (ZALs) that are uniquely able to (co)deliver long RNAs including Cas9 mRNA and sgRNAs. ZAL nanoparticle (ZNP) delivery of low sgRNA doses (15 n m) reduces protein expression by >90 % in cells. In contrast to transient therapies (such as RNAi), we show that ZNP delivery of sgRNA enables permanent DNA editing with an indefinitely sustained 95 % decrease in protein expression. ZNP delivery of mRNA results in high protein expression at low doses in vitro (<600 pM) and in vivo (1 mg kg−1). Intravenous co-delivery of Cas9 mRNA and sgLoxP induced expression of floxed tdTomato in the liver, kidneys, and lungs of engineered mice. ZNPs provide a chemical guide for rational design of long RNA carriers, and represent a promising step towards improving the safety and utility of gene editing. [ABSTRACT FROM AUTHOR]